Biocon Biologics announces new dermatology data to be presented at EADV Congress 2024
Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Catalytic Droplets leading to faster chemical reactions can bring quicker access to innovative…
Scientists at INST, Mohali, an autonomous institute of the Department of Science and Technology explored a way to confine…
Sun Pharma and Moebius Medical gain fast track designation for MM-II for the treatment of…
MM-II is a novel non-opioid product that uses a proprietary suspension of large, empty, multilamellar liposomes which are intended…
Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised…
Cladribine capsules have the potential to be the first oral treatment for gMG patients
Tonix gives update on development of its single-dose live attenuated virus vaccine candidate for…
TNX-801 is a live replicating attenuated vaccine candidate based on horsepox that is believed to provide immune protection with…
Drug delivery method can improve fungal infection treatment
A team of scientists from Agharkar Research Institute have used a chitin synthesis fungicide, Nikkomycin, produced by the…
Pfizer, BioNTech give update on mRNA-based combination vaccine programme
The combination candidate consists of Pfizer’s mRNA-based influenza vaccine candidate with the companies’ licensed COVID-19…
Computational protocol provides cheaper route to manage cholesterol levels
Researchers propose a new computational protocol to predict and identify the alternative binding pockets and hotspots on a protein…
FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death
The study could be of high clinical value to cardiologists who are seeking an optimal treatment of choice for HF patients, which…
Dual-action therapy shows promise against aggressive oral cancer
A new treatment combining tiny iron particles and nitric oxide gas shows promise in targeting oral cancer cells for destruction
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says…
Leqembi is the only approved treatment in China that has shown efficacy in slowing the progression of Alzheimer’s by directly…
NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical…
According to GlobalData, NewAmsterdam’s obicetrapib is expected to be the most promising agent to launch in the dyslipidemia…
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData
According to GlobalData epidemiologists, there were 19.90 per cent of stage III diagnosed incident cases of RCC and 17.90 per cent…
Recent study shows BioCity’s potential to differentiate in kidney disease space
The study could be of high clinical value to nephrologists who are seeking an optimal treatment of choice for IgAN patients, which…
SynaptixBio collaborates with Evotec to boost search for rare disease therapies
SynaptixBio and Evotec are working to develop new candidate therapies for a specific leukodystrophy
Synergistic safety profile could increase sublingual apomorphine competitiveness: GlobalData
New findings from EAN 2024 highlight potential competitive edge for Kynmobi in managing levodopa Wear-Off
Penn pioneers a ‘one-pot platform’ to promptly produce mRNA delivery particles
New lipid platform enables rapid synthesis of molecules that can shuttle therapeutics for a range of diseases with a high degree…
Healey platform data to pave phase III path for Prilenia’s pridopidine: GlobalData
Prilenia Therapeutics presented promising results from the additional analyses of the Phase II Healey ALS Platform Trial…
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData
The combination therapy demonstrated significant improvements in seizure control, highlighting its potential as a safe and…